You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ladarixin

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced NSCLC With KRAS G12C Mutation Trial in New York (Sotorasib, Ladarixin)

Not yet recruiting
  • Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation
  • New York, New York
    NYU Langone Health
Apr 4, 2023

Advanced NSCLC With KRAS G12C Mutation Trial in New York (Sotorasib, Ladarixin)

Not yet recruiting
  • Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation
  • New York, New York
    NYU Langone Health
Apr 4, 2023

Type 1 Diabetes Trial in Pittsburgh, Frosinone, Rome (Ladarixin, Placebo)

Recruiting
  • Type 1 Diabetes
  • Ladarixin
  • Placebo
  • Pittsburgh, Pennsylvania
  • +2 more
Nov 21, 2022

Type I Diabetes Trial in Pittsburgh (Ladarixin, Placebo)

Withdrawn
  • Type I Diabetes
  • Ladarixin
  • Placebo
  • Pittsburgh, Pennsylvania
    Institute of Cellular Therapeutics Allegheny Health Network
Jan 17, 2022

no Condition Trial in Arzo (Ladarixin)

Completed
Has Results
  • no Condition
  • Ladarixin
  • Arzo, Canton Ticino, Switzerland
    CROSS Research S.A., I Unit
Jan 10, 2022

Diabetes, Insulin-Dependent Trial in Belgium, Germany, Italy (Ladarixin, Placebo)

Completed
Has Results
  • Diabetes Mellitus, Insulin-Dependent
  • Ladarixin
  • Placebo
  • Brussels, Belgium
  • +7 more
Sep 23, 2021

New-onset type1 Diabetes Trial in Worldwide (Ladarixin, Placebo)

Recruiting
  • New-onset type1 Diabetes
  • Ladarixin
  • Placebo
  • Birmingham, Alabama
  • +57 more
Nov 21, 2022